Quantum Cloud Partnerships And Government Support Will Drive Long Term Upside Potential

Catalysts

About Quantinuum

Quantinuum develops full stack quantum computing systems that combine hardware, software and applications for enterprise and research use.

What are the underlying business or industry changes driving this perspective?

• Helios systems are already in commercial use and Quantinuum has a defined road map to Sol in 2027 and Apollo in 2029. This positions the company to convert a growing multi year pipeline into higher system and cloud revenue as more capacity comes online.
• The letter of intent with the U.S. Department of Commerce CHIPS R&D Office for up to US$100 million, combined with long term partnerships with GlobalFoundries, Honeywell Aerospace, Infineon and Monarch Quantum, supports onshore manufacturing and supply chain resilience that can help scale volumes and improve long run unit economics and gross margins.
• Deep integration of Helios into Oracle Cloud Infrastructure and the collaboration framework with HPE for high performance computing create a path for wider enterprise access to Quantinuum’s hardware and Nexus platform. This can lift recurring cloud and software revenue as usage expands across AI and HPC workloads.
• More than 180 organizations are building on the Nexus platform and usage intensity is rising. This increases the likelihood of stickier developer relationships and higher value software, services and consumption based revenue that can support margin expansion over time.
• New code families delivering near 99.999% logical fidelity on Helios, combined with progress on scalable 2D QCCD architectures for Sol and Apollo, point to higher quality computation that can make more complex optimization, chemistry and materials workloads commercially viable and support future growth in bookings, backlog and earnings potential.

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more optimistic perspective on Quantinuum compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
• The bullish analysts are assuming Quantinuum's revenue will grow by 156.6% annually over the next 3 years.
• The bullish analysts are not forecasting that Quantinuum will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Quantinuum's profit margin will increase from -742.5% to the average US IT industry of 8.1% in 3 years.
• If Quantinuum's profit margin were to converge on the industry average, you could expect earnings to reach $31.4 million (and earnings per share of $1.06) by about August 2029, up from -$170.6 million today.
• In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 165.2x on those 2029 earnings, up from -11.7x today. This future PE is greater than the current PE for the US IT industry at 16.7x.
• The bullish analysts expect the number of shares outstanding to decline by 7.0% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 9.19%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?

• Quantinuum is still in a heavy investment phase with a non-GAAP net loss of $73 million in Q2 2026 and an adjusted EBITDA loss of $68 million, while R&D, sales and marketing and G&A are all running at high levels. If revenue remains relatively small compared with this cost base, the company may need to keep funding sizeable operating losses for longer than investors expect, which would pressure earnings and delay any path to net margin improvement.
• The commercial model depends on converting a very large multi year pipeline and remaining performance obligations into recognized revenue. Management highlights that revenue timing can be lumpy and that system sales and long term cloud contracts often recognize revenue over several years. If contract structures, implementation timelines or customer usage patterns slow this conversion, reported revenue and earnings could fall short of expectations even if bookings appear healthy.
• Quantinuum’s roadmap rests on delivering Sol in 2027 and Apollo in 2029, with Lumos as a follow on, and on scaling complex manufacturing through partners such as GlobalFoundries, Honeywell Aerospace, Infineon and Monarch Quantum. Any technical setbacks in 2D QCCD architectures, quantum error correction, cryogenic systems or multi tile scaling, or any delays in partner execution, could postpone product rollouts and reduce the speed at which new systems contribute to revenue and gross margin.
• The long term thesis assumes that a broad developer and enterprise ecosystem will form around the Nexus platform, Guppy language and GenQAI use cases. Today Quantinuum cites about 180 organizations on Nexus and is still building its indirect channel with partners such as Oracle and HPE. If developer adoption, usage intensity or enterprise workflows incorporating quantum progress more slowly than management anticipates, cloud and software revenue may not scale as expected and operating margins could stay weak.
• Government funding and policy support, including the U.S. Department of Commerce CHIPS R&D LOI for up to $100 million and broader U.S. quantum initiatives, are important for Quantinuum’s onshore supply chain and advanced manufacturing plans. If future government priorities, budgets or milestone based payments under these programs are reduced, delayed or redirected, the company could face higher capital requirements and less favorable unit economics, which would weigh on free cash flow and net income over the long term.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bullish price target for Quantinuum is $134.36, which represents up to two standard deviations above the consensus price target of $97.17. This valuation is based on what can be assumed as the expectations of Quantinuum's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $155.0, and the most bearish reporting a price target of just $78.0.
• In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be $388.1 million, earnings will come to $31.4 million, and it would be trading on a PE ratio of 165.2x, assuming you use a discount rate of 9.2%.
• Given the current share price of $53.89, the analyst price target of $134.36 is 59.9% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.